PPT-Safety Considerations in Phase 1 Trials
Sumathi Nambiar MD MPH Director Division of AntiInfective Products November 7 2016 Outline General considerations with clinical trials early in development Predictable
Download Presentation
"Safety Considerations in Phase 1 Trials" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.